¼¼°èÀÇ °¡»ó Áø·á ½ÃÀå
Virtual Care
»óǰÄÚµå : 1799221
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 174 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,233,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,701,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ °¡»ó Áø·á ½ÃÀåÀº 2030³â±îÁö 517¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 139¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â °¡»ó Áø·á ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 24.5%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 517¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¼Ö·ç¼Ç ÄÄÆ÷³ÍÆ®´Â CAGR 21.7%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 286¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼­ºñ½º ÄÄÆ÷³ÍÆ® ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 28.9%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 36¾ï ´Þ·¯, Áß±¹Àº CAGR 23.4%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹Ãø

¹Ì±¹ÀÇ °¡»ó Áø·á ½ÃÀåÀº 2024³â¿¡ 36¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 79¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 23.4%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 22.0%¿Í 21.4%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 17.2%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ °¡»ó Áø·á ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¿Ö °¡»ó Áø·á°¡ ÆÒµ¥¹Í ½Ã´ëÀÇ Çʼöǰ¿¡¼­ Àå±âÀûÀÎ ÇコÄɾîÀÇ ÇʼöǰÀ¸·Î ÀüȯµÇ°í Àִ°¡?

È­»óÁø·á, ¿ø°ÝÁø·á, ¿ø°ÝÁø´Ü, ¿ø°ÝÄ¡·á, µðÁöÅÐ ¸¸¼º±â ÀÇ·á°ü¸® µîÀ» Æ÷°ýÇÏ´Â °¡»óÄɾî´Â ´õ ÀÌ»ó ÀӽùæÆíÀûÀÎ ¼Ö·ç¼ÇÀ¸·Î °£ÁÖµÇÁö ¾Ê½À´Ï´Ù. °¡»ó Áø·á´Â ÆÒµ¥¹Í(¼¼°èÀû ´ëÀ¯Çà)À» °è±â·Î ±Þ¼ÓÈ÷ È®»êµÇ¾úÁö¸¸, ÁÖ·ù ÀÇ·á ¼­ºñ½º Á¦°ø¿¡ Áö¼ÓÀûÀ¸·Î ÅëÇյǸ鼭 ±× °ü·Ã¼ºÀº º¯ÇÔ¾ø½À´Ï´Ù´Â °ÍÀÌ ¹àÇôÁ³½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î´Â ÆíÀǼº¿¡ ´ëÇÑ È¯ÀÚµéÀÇ ±â´ëÄ¡ »ó½Â, ¸¸¼ºÁúȯ ºÎ´ãÀÇ ±ÞÁõ, ÀÓ»óÀÇ»ç ºÎÁ·, ÀÇ·á¼­ºñ½º ¼Ò¿Ü°èÃþ¿¡ ´ëÇÑ Á¢±Ù¼º È®´ë Çʿ伺 µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ÁöºÒÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü°¡ °¡Ä¡ ±â¹Ý Áø·á ¸ðµ¨¿¡ ÀûÀÀÇÔ¿¡ µû¶ó, °¡»ó Áø·á´Â ºñ¿ë È¿À²ÀûÀ̰í È®Àå °¡´ÉÇϸç Áö¼ÓÀûÀÎ Áø·á¸¦ Á¦°øÇϱâ À§ÇÑ Áß¿äÇÑ ¼ö´ÜÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.

º´¿ø, º¸Çè»ç, ÅëÇÕ ÀÇ·á ³×Æ®¿öÅ©´Â 1Â÷ Áø·á °æ·Î, Çൿ °Ç°­ ÇÁ·Î±×·¥, »çÈÄ Ä¡·á, ´ç´¢º´ °ü¸® ¹× ½ÉÀå ÀçȰ°ú °°Àº Áúº´º° ÁßÀç¿¡ °¡»ó Áø·á¸¦ ÅëÇÕÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÇÏÀ̺긮µå ÄÉ¾î ¸ðµ¨ÀÇ È®»êÀº ´ë¸é Áø·á¿Í °¡»ó Áø·á¸¦ ÅëÇÕÇÏ´Â ¿öÅ©Ç÷ο츦 À籸¼ºÇÏ¿© Áø·áÀÇ ¿¬¼Ó¼ºÀ» ÃÖÀûÈ­Çϰí ÀÖ½À´Ï´Ù. ºê·Îµå¹êµå, 5G, º¸¾È µ¥ÀÌÅÍ Ç÷§Æû¿¡ ´ëÇÑ ÀÎÇÁ¶ó ÅõÀÚ°¡ ÃËÁøµÇ°í, °¡»ó Áø·á´Â »óÈ£¿î¿ë¼º°ú ÀÓ»óÀû ½Å·Ú¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. µðÁöÅÐ µµ±¸¸¦ Ȱ¿ëÇÑ ¿¡ÇǼҵåÇü¿¡¼­ Á¾´ÜÀû ȯÀÚ Âü¿©·ÎÀÇ ÀüȯÀº ÀÇ·á ¼­ºñ½º Á¢±Ù ¹× Á¦°ø ¹æ½ÄÀ» °è¼ÓÇØ¼­ ÀçÁ¤ÀÇÇϰí ÀÖ½À´Ï´Ù.

µðÁöÅÐ ±â¼úÀÌ °¡»ó Áø·á Ç÷§Æû°ú ÀÓ»ó ¿öÅ©Ç÷ο츦 ¾î¶»°Ô °­È­Çϴ°¡?

AI¿Í ÀÚµ¿È­¸¦ ÅëÇØ °¡»ó Áø·á Ç÷§ÆûÀº Áö´ÉÇü ÀÇ·á ¿ÀÄɽºÆ®·¹ÀÌ¼Ç µµ±¸·Î º¯¸ðÇϰí ÀÖ½À´Ï´Ù. AI¸¦ Ȱ¿ëÇÑ Áõ»ó °Ë»ç±â, ¼±º°Áø·á ·Îº¿, ÀÚµ¿È­µÈ EHR ¹®¼­È­ ¹× ÀÓ»óÀû ÆÇ´Ü Áö¿ø±îÁö, ±â¼úÀº °ü¸®»óÀÇ ¸¶ÂûÀ» ÃÖ¼ÒÈ­Çϰí ÀÓ»óÀÇÀÇ È¿À²À» ³ô¿©ÁÖ°í ÀÖ½À´Ï´Ù. ÀÚ¿¬¾î ó¸®(NLP) µµ±¸´Â ½Ç½Ã°£ È­»ó Áø·á ³ìÃë, ICD ÄÚµå űë, ȯÀÚ Â÷Æ® ÀÚµ¿ ÀԷ¿¡ ÅëÇյǾî ÀÖ½À´Ï´Ù. ÇÑÆí, ºí·çÅõ½º Áö¿ø Ç÷´ç ÃøÁ¤±â, ¸Æ¹Ú »ê¼Ò ÃøÁ¤±â, ¿þ¾î·¯ºíÀ» ÀÌ¿ëÇÑ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM) µµ±¸´Â ½Ç½Ã°£ °Ç°­ µ¥ÀÌÅ͸¦ ÀÇ·áÁøÀÇ ´ë½Ãº¸µå¿¡ Á÷Á¢ Àü´ÞÇϰí ÀÖ½À´Ï´Ù.

Ŭ¶ó¿ìµå ³×ÀÌÆ¼ºê ¾ÆÅ°ÅØÃ³¿Í API ±â¹ÝÀÇ »óÈ£¿î¿ë¼ºÀ» ÅëÇØ °¡»ó Áø·á Ç÷§ÆûÀº °Ë»ç ½Ã½ºÅÛ, ¹æ»ç¼± Æ÷ÅÐ, ÀüÀÚó¹æ ½Ã½ºÅÛ°ú ¿øÈ°ÇÏ°Ô ÅëÇÕÇÒ ¼ö ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ °¡»ó Áø·á´Â µ¶¸³ÀûÀÎ °ÍÀÌ ¾Æ´Ï¶ó ÀϰüµÈ Áø·á ¿©Á¤ÀÇ ÀϺΰ¡ µÉ ¼ö ÀÖ½À´Ï´Ù. À½¼º ÀÎ½Ä AI ºñ¼­, ½º¸¶Æ® ½ºÄÉÁÙ¸µ ¿£Áø, »ýü ÀÎÁõÀº ȯÀÚ¿Í ÀÇ·áÁøÀÇ °æÇèÀ» ´õ¿í dz¿ä·Ó°Ô Çϰí ÀÖ½À´Ï´Ù. »çÀ̹ö º¸¾ÈÀÌ ÃÖ¿ì¼± °úÁ¦·Î ¶°¿À¸£°í ÀÖ´Â °¡¿îµ¥, ¹öÃß¾ó Äɾî Ç÷§ÆûÀº °íµµÀÇ ¾Ïȣȭ, ´Ù´Ü°è ÀÎÁõ, ¿ªÇÒ ±â¹Ý Á¢±Ù Á¦¾î¸¦ µµÀÔÇÏ¿© µ¥ÀÌÅÍ º¸¾È°ú ±ÔÁ¦ Áؼö¸¦ º¸ÀåÇÕ´Ï´Ù.

°¡Àå ºü¸£°Ô µµÀԵǰí Àִ ȯÀÚ±º°ú ÀÓ»ó ¿µ¿ªÀº?

°¡»ó Áø·á¿¡¼­ °¡Àå Æø¹ßÀûÀÎ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ´Â ºÐ¾ß´Â Çൿ ¹× Á¤½ÅÀÇÇÐ ºÐ¾ß·Î, ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üµéÀº ¾ÈÀüÇÑ È­»ó Ç÷§ÆûÀ» ÅëÇØ Ä¡·á, Á¤½Å°¨Á¤, ¾à¹° ³²¿ë »ó´ã µîÀ» Á¦°øÇÕ´Ï´Ù. ¸¸¼ºÁúȯ °ü¸®µµ Áß¿äÇÑ ºÐ¾ß·Î, ƯÈ÷ °íÇ÷¾Ð, COPD, 2Çü ´ç´¢º´ µî Àå±âÀûÀÎ ¸ð´ÏÅ͸µ°ú ±³À°ÀÌ ÇÊ¿äÇÑ ÁúȯÀ» ´ë»óÀ¸·Î ÇÕ´Ï´Ù. °¡»ó Áø·á´Â ÀÌ·¯ÇÑ È¯ÀÚµéÀÌ º´¿øÀ» ¹æ¹®ÇØ¾ß ÇÏ´Â ¹°·ùÀû ºÎ´ãÀ» ´ú°í, ´õ ÀÚÁÖ ÀÇ·áÁø°ú ¼ÒÅëÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á º¹¾à ¼øÀÀµµ¸¦ ³ôÀ̰í ÇÕº´ÁõÀ» Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù.

Áö¹æ°ú ¿ÀÁöÀÇ »ç¶÷µéµµ Áß¿äÇÑ ¼öÇýÀÚÀÔ´Ï´Ù. ÀÇ»ç ºÎÁ·°ú Áö¸®Àû À庮ÀÌ ÀÖ´Â Áö¿ª¿¡¼­´Â °¡»ó Áø·á°¡ Áß¿äÇÑ Á¢±Ù¼º °ÝÂ÷¸¦ ÇØ¼ÒÇϰí ÀÖ½À´Ï´Ù. °í·ÉÀÇ È¯ÀÚ, ƯÈ÷ ¿©·¯ ÁúȯÀ» ¾Î°í Àִ ȯÀÚµéÀº ¿ø°ÝÁø·á¿Í ¿¬°áµÈ ÀÇ·á±â±â¸¦ ÅëÇÑ ÀçÅÃÀÇ·áÀÇ ÇýÅÃÀ» ´©¸®°í ÀÖ½À´Ï´Ù. ¼Ò¾Æ°ú, ÇǺΰú, »ý½ÄÀÇÇÐ, Á¾¾çÇÐ µîÀÇ ÈÄ¼Ó Áø·á´Â 3Â÷ ÀÇ·á±â°ü¿¡¼­ÀÇ Ä¡·á Áö¿¬°ú ȯÀÚ ºÎ´ãÀ» ÁÙÀ̱â À§ÇØ °¡»ó ¸ðµ¨À» ÅëÇØ Á¦°øµÇ´Â °æ¿ì°¡ ´Ã°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °í¿ëÁÖ°¡ ÈÄ¿øÇÏ´Â °¡»ó ÄÉ¾î ¼­ºñ½ºµµ Áõ°¡Çϰí ÀÖÀ¸¸ç, ƯÈ÷ ÀÚ°¡º¸Çè °¡ÀÔ ±â¾÷µé »çÀÌ¿¡¼­ °á±Ù ¹× ÀÇ·áºñ Àý°¨À» À§ÇÑ °¡»ó ÄÉ¾î ¼­ºñ½º°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

°¡»ó ÄÉ¾î ½ÃÀåÀÇ Áö¼ÓÀûÀÎ ¼ºÀå ¿äÀÎÀº?

°¡»ó Áø·á ½ÃÀåÀÇ ¼ºÀåÀº ȯÀÚ ÇൿÀÇ º¯È­, ºñ¿ë ¾ïÁ¦¿¡ ´ëÇÑ ÁöºÒÀÚ¿Í ÀÇ·á Á¦°ø¾÷üÀÇ Çù·Â, ½ÇÇö ±â¼úÀÇ ¼º¼÷ µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ȯÀÚµéÀº Á¡Á¡ ´õ ¼ÒºñÀÚ µðÁöÅÐ ¼­ºñ½ºÀÇ ÆíÀǼº°ú Á¢±Ù¼º¿¡ °É¸Â´Â ÀÇ·á ¼­ºñ½º¸¦ ¿ä±¸Çϰí ÀÖ½À´Ï´Ù. µ¿½Ã¿¡ Á¤ºÎ¿Í º¸Çè»ç´Â ¿ø°Ý ÀÇ·á ¼­ºñ½º¸¦ ´ë±Ô¸ð·Î ½ÇÇàÇÒ ¼ö ÀÖµµ·Ï »óȯ ÇÁ·¹ÀÓ¿öÅ©¸¦ ¾÷µ¥ÀÌÆ®Çϰí ÀÖÀ¸¸ç, ÆÒµ¥¹Í ±â°£ µ¿¾È µµÀÔµÈ ¸¹Àº À¯¿¬¼ºÀ» ¿µ±¸ÀûÀ¸·Î È®ÀåÇϰí ÀÖ½À´Ï´Ù.

ÀÇ·á ½Ã½ºÅÛ, ±â¼ú Á¦°ø¾÷ü, µðÁöÅÐ Çコ ½ºÅ¸Æ®¾÷ °£ÀÇ Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ÅëÇØ Ç÷§Æû °³¹ß ¹× ÀÇ·á Çõ½ÅÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. º¥Ã³±â¾÷ÀÇ ÀÚ±Ý Á¶´ÞÀº °¡»ó ÆÛ½ºÆ® ÄÉ¾î ¸ðµ¨, ¿ø°Ý Áø´Ü, ÇÏÀ̺긮µå Ŭ¸®´Ð¿¡ Áö¼ÓÀûÀ¸·Î À¯ÀԵǰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀåÀÇ ½Å·Ú°¡ Áö¼ÓµÇ°í ÀÖÀ½À» º¸¿©ÁÝ´Ï´Ù. ÇÑÆí, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹× °ü¸® Ç¥ÁØÈ­¸¦ µÑ·¯½Ñ ±ÔÁ¦ ³ë·ÂÀº ÀÌ ºÐ¾ß¸¦ ¾ÈÁ¤È­½ÃŰ°í ½Å·Ú¸¦ Á¶¼ºÇϰí ÀÖ½À´Ï´Ù. AI¸¦ Ȱ¿ëÇÑ ¼±º°Áø·á, ºñµ¿±â½Ä ¸Þ½Ã¡, °¡»ó Àü¹® Ŭ¸®´ÐÀÌ º¸ÆíÈ­µÊ¿¡ µû¶ó °¡»ó Áø·á´Â ´ë¾ÈÀÌ ¾Æ´Ñ ÇÙ½É Àü´Þ ä³Î·Î ÁøÈ­ÇÏ¿© ÇコÄɾîÀÇ Àü¸ÁÀ» º¸´Ù ºÐ»êÀûÀ̰í, Àû±ØÀûÀ̸ç, °øÆòÇÏ°Ô ÀçÆíÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ºÎ¹®

ÄÄÆ÷³ÍÆ®(¼Ö·ç¼Ç, ¼­ºñ½º), Àü°³(ºñµð¿À ±â¹Ý ¸ðµå, ¿Àµð¿À ±â¹Ý ¸ðµå, ¸Þ½Ã¡ ±â¹Ý ¸ðµå), ÃÖÁ¾»ç¿ëÀÚ(ÀçÅà ÇコÄɾî ÃÖÁ¾»ç¿ëÀÚ, º´¿ø ÃÖÁ¾»ç¿ëÀÚ, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Virtual Care Market to Reach US$51.7 Billion by 2030

The global market for Virtual Care estimated at US$13.9 Billion in the year 2024, is expected to reach US$51.7 Billion by 2030, growing at a CAGR of 24.5% over the analysis period 2024-2030. Solutions Component, one of the segments analyzed in the report, is expected to record a 21.7% CAGR and reach US$28.6 Billion by the end of the analysis period. Growth in the Services Component segment is estimated at 28.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.6 Billion While China is Forecast to Grow at 23.4% CAGR

The Virtual Care market in the U.S. is estimated at US$3.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.9 Billion by the year 2030 trailing a CAGR of 23.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 22.0% and 21.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 17.2% CAGR.

Global Virtual Care Market - Key Trends & Drivers Summarized

Why Is Virtual Care Transitioning from a Pandemic-Era Necessity to a Long-Term Healthcare Staple?

Virtual care, encompassing video consultations, remote diagnostics, teletherapy, and digital chronic care management, is no longer seen as an interim solution. The pandemic may have catalyzed its rapid adoption, but the continued integration of virtual care into mainstream healthcare delivery highlights its enduring relevance. Key drivers include rising patient expectations for convenience, the surge in chronic illness burden, clinician shortages, and the need to expand access to underserved populations. As payers and providers adapt to value-based care models, virtual care has emerged as a critical lever for delivering cost-effective, scalable, and continuous care.

Hospitals, insurers, and integrated health networks are embedding virtual care into primary care pathways, behavioral health programs, post-acute care, and disease-specific interventions such as diabetes management or cardiac rehabilitation. Additionally, the proliferation of hybrid care models is reshaping workflows to blend in-person and virtual consultations for optimized care continuity. With infrastructure investments in broadband, 5G, and secure data platforms gaining traction, virtual care is becoming more interoperable and clinically reliable. The transition from episodic to longitudinal patient engagement-powered by digital tools-continues to redefine how care is accessed and delivered.

How Are Digital Technologies Enhancing Virtual Care Platforms and Clinical Workflows?

AI and automation are transforming virtual care platforms into intelligent health orchestration tools. From AI-powered symptom checkers and triage bots to automated EHR documentation and clinical decision support, technology is minimizing administrative friction and enhancing clinician efficiency. Natural language processing (NLP) tools are being integrated to transcribe video consultations in real time, tag ICD codes, and auto-populate patient charts. Meanwhile, remote patient monitoring (RPM) tools-using Bluetooth-enabled glucometers, pulse oximeters, and wearables-are delivering real-time health data directly into provider dashboards.

Cloud-native architectures and API-driven interoperability allow virtual care platforms to integrate seamlessly with lab systems, radiology portals, and electronic prescribing systems. This ensures that virtual visits aren’t standalone encounters but part of a cohesive care journey. Voice-enabled AI assistants, smart scheduling engines, and biometric authentication are further enriching the patient and provider experience. As cybersecurity becomes a top priority, virtual care platforms are implementing advanced encryption, multi-factor authentication, and role-based access controls to ensure data security and regulatory compliance.

Which Patient Segments and Clinical Areas Are Driving Adoption Most Rapidly?

Behavioral and mental health have seen the most explosive growth in virtual care, with providers offering therapy, psychiatric assessments, and substance abuse counseling through secure video platforms. Chronic disease management is another key segment, especially for conditions requiring long-term monitoring and education such as hypertension, COPD, and Type 2 diabetes. Virtual care is enabling these patients to engage with care teams more frequently without the logistical burden of clinic visits, resulting in improved adherence and early detection of complications.

Rural and remote populations are also key beneficiaries. In regions with clinician shortages and geographic barriers, virtual care bridges critical access gaps. Elderly patients, particularly those managing multiple co-morbidities, are benefiting from home-based care via teleconsultation and connected health devices. Pediatrics, dermatology, reproductive health, and oncology follow-ups are increasingly being delivered through virtual models to reduce care delays and patient load at tertiary centers. Additionally, employer-sponsored virtual care services are on the rise, especially among self-insured companies looking to reduce absenteeism and healthcare costs.

What Factors Are Fueling the Continued Growth of the Virtual Care Market?

The growth in the virtual care market is driven by several factors, including shifting patient behavior, payer-provider alignment on cost containment, and the maturation of enabling technologies. Patients are increasingly demanding healthcare that matches the convenience and accessibility of consumer digital services. At the same time, governments and insurers are updating reimbursement frameworks to make telehealth services viable at scale-permanently extending many of the flexibilities introduced during the pandemic.

Strategic partnerships between health systems, technology providers, and digital health startups are accelerating platform development and care innovation. Venture funding continues to flow into virtual-first care models, remote diagnostics, and hybrid clinics, signaling sustained market confidence. Meanwhile, regulatory efforts around data privacy and care standardization are stabilizing the sector and fostering trust. As AI-enabled triage, asynchronous messaging, and virtual specialty clinics become commonplace, virtual care will evolve into a core delivery channel rather than an alternative-reshaping the healthcare landscape into one that is more distributed, proactive, and equitable.

SCOPE OF STUDY:

The report analyzes the Virtual Care market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Solutions Component, Services Component); Deployment (Video-based Mode, Audio-based Mode, Messaging-based Mode); End-User (Home Healthcare End-User, Hospitals End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â